Gender differences in aminoglycoside induced nephrotoxicity: A prospective, hospital - Based study

Current Clinical Pharmacology

Volumn 4, Issue 3, 2009, Pages 229-232

  Sweileh, Waleed M ^a  

^a AN NAJAH NATIONAL UNIVERSITY   (Palestine)

Author keywords

Amikacin; Gender; Gentamicin; Nephrotoxicity

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CREATININE; GENTAMICIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DEMOGRAPHY; DISEASE PREDISPOSITION; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMIKACIN; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; CREATININE; FEMALE; GENTAMICINS; HUMANS; INPATIENTS; KIDNEY DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TIME FACTORS; UP-REGULATION; YOUNG ADULT;

EID: 70549110031     PISSN: 15748847     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488409789375339     Document Type: Article

References (18)

1. Drusano GL, Ambrose PG, Bhavnani SM, et al. Back to the future: using aminoglycosides again and how to dose them optimally. Clin Infect Dis 2007; 45(6): 753-760
2. Martínez-Salgado C, López-Hernández FJ, López-Novoa JM. Glomerular nephrotoxicity of aminoglycosides. Toxicol Appl Pharmacol 2007; 223(1): 86-98.
3. Ali BH. Gentamicin nephrotoxicity in humans and animals: some recent research. Gen Pharmac 1995; 26: 1477-1482
4. Baciewicz AM, Sokos DR, Cowan RI. Aminoglycoside-associated nephrotoxicity in the elderly. Ann Pharmacother 2003; 37(2): 182-186
5. Swan SK. Aminoglycoside nephrotoxicity. Semin Nephrol 1997; 17(1): 27-33.
6. Bennett WM, Parker RA, Elliot WC, Gilbert D, Houghton D. Sex-related differences in the susceptibility of rats to gentamicin nephrotoxicity. J Infect Dis 1982; 145: 370-374
7. Ballesteros J, Northland R, Wolff M. Gentamicin and amikacin nephrotoxicity: comparative study in patients with initially normal renal function. Rev Med Chil 1989; 117(1): 10-17
8. French MA, Cerra FB, Plaut ME, Schentag JJ. Amikacin and gentamicin accumulation pharmacokinetics and nephrotoxicity in critically ill patients. Antimicrob Agents Chemother 1981; 19(1): 147-152
9. Lerner SA, Schmitt BA, Seligsohn R, Matz GJ. Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin. Am J Med 1986; 30: 80(6B): 98-104. (Pubitemid 16036773)
10. Goodrich JA, Hottendorf GH. Tobramycin gender-related nephrotoxicity in Fischer but not Sprague-Dawely rats. Toxicol Lett 1995; 75: 127-131
11. Miura K, Pasino DA, Goldstein RS, Hook JB. Effects of gentamicin on renal function in isolated perfused kidneys from male and female rats. Toxicol Lett 1985; 26: 15-18. (Pubitemid 15233257)
12. Gouvea W, Vaamonde C M, Owens B, et al. The protection against gentamicin nephrotoxicity in streptozotocin induced diabetic rat is not related to gender. Life Sci 1992; 51: 1747-1758
13. Ali BH, Ben Ismail TH, Bashir AA. Sex differences in the susceptibility of rats to gentamicin nephrotoxicty: influence of gonadoctomy and hormonal replacement therapy. Indian J Pharmacol 2001; 33: 369-373
14. Moore RD, Smith CVR, Lipsky JJ, Mellits ED, Lietman P. Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Int Med 1984; 100: 352-357
15. Bertino JS, Booker LA, Frank PA, Nafizer AN. Incidences of and significant risk factors for aminoglycoside- associ-ated nephrotoxicity in patients. J Infect Dis 1984; 167: 173-179
16. Carraro-Eduardo JC, Oliveira AV, Carrapatoso ME, Ornellas JF. Effect of sex hormones on gentamicin-induced nephrotoxicity in rats. Braz J Med Biol Res 1993; 26: 653-662 (Pubitemid 23211453)
17. Crann SA, Huang MY, McLaren JD, Schacht J. Formation of a toxic metabolite from gentamicin by a hepatic cytosolic fraction. Biochem Pharmacol 1992; 43: 1835-1839
18. Williams PD, Bennett DB, Gleason CR, Hottendorf GH. Correlation between renal membrane binding and nephrotoxicity of aminoglycosides. Antimicrob Agents Chemother 1987; 31: 570-574